Efgartigimod Co-administered Subcutaneously With rHuPH20 in Healthy Subjects

Clinical trial NCT04073589 · COMPLETED

Trial details

NCT number: NCT04073589
Sponsor: argenx
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2019-07-17
Primary completion: 2019-09-26
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.